Zhen Cai
-
- Cancer, Hypoxia, and Metabolism 4
-
- Metabolism, Diabetes, and Cancer 4
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 2
- Cancer-related gene regulation 2
- Pluripotent Stem Cells Research 1
- Mitochondrial Function and Pathology 1
-
- interferon and immune responses 1
- Journals
- Nature Communications (1 paper)Nature Cell Biology (3 papers)Applied and Environmental Microbiology (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Zhen Cai
9 papers receiving 589 citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Cancer Research 149
- Molecular Biology 475
- Oncology 81
- Immunology 62
- Geriatrics and Gerontology 9
Countries citing papers authored by Zhen Cai
This map shows the geographic impact of Zhen Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Cai more than expected).
Fields of papers citing papers by Zhen Cai
This network shows the impact of papers produced by Zhen Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Cai. The network helps show where Zhen Cai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhen Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistancebreakdown → | 2023 | 121 |
| 3 | 2022 | 9 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 146 | |
| 6 | 2020 | 7 | |
| 7 | 2019 | 22 | |
| 8 | 2019 | 143 | |
| 9 | 2018 | 139 |
About Zhen Cai
Zhen Cai is a scholar working on Cancer Research, Molecular Biology and Food Science, having authored 9 papers that have together received 593 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (2 papers), Cancer-related gene regulation (2 papers), interferon and immune responses (1 paper), Pluripotent Stem Cells Research (1 paper) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Cancer Research (149 citations), Molecular Biology (475 citations) and Oncology (81 citations). Zhen Cai has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Hui‐Kuan Lin, Che-Chia Hsu, Danni Peng, Fei Han, Chuan Xu, Guoxiang Jin, Chi‐Yun Wang, Dazhi Xu, Xian Zhang and John Kenneth Morrow. Their work appears in journals such as Nature Communications, Nature Cell Biology and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.